BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 28834261)

  • 1. Potential savings in the diagnosis of vestibular schwannoma.
    Scholte M; Hentschel MA; Kunst HP; Steens SCA; Rovers MM; Grutters JPC
    Clin Otolaryngol; 2018 Feb; 43(1):285-290. PubMed ID: 28834261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory brainstem response prior to MRI compared to standalone MRI in the detection of vestibular schwannoma: A modelling study.
    Wijn SRW; Hentschel MA; Beynon AJ; Kunst HPM; Rovers MM
    Clin Otolaryngol; 2022 Mar; 47(2):295-303. PubMed ID: 34784107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of vestibular schwannoma screening with contrast-enhanced magnetic resonance imaging in patients with asymmetrical hearing loss.
    Pan P; Huang J; Morioka C; Hathout G; El-Saden SM
    J Laryngol Otol; 2016 Jan; 130(1):21-4. PubMed ID: 26365591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In search of the most cost-effective monitoring strategy for vestibular schwannoma: A decision analytical modelling study.
    Scholte M; Hentschel MA; Hannink G; Kunst HPM; Steens SC; Rovers MM; Grutters JPC
    Clin Otolaryngol; 2019 Jul; 44(4):525-533. PubMed ID: 30864276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of a non-contrast screening MRI protocol for vestibular schwannoma in patients with asymmetric sensorineural hearing loss.
    Crowson MG; Rocke DJ; Hoang JK; Weissman JL; Kaylie DM
    Neuroradiology; 2017 Aug; 59(8):727-736. PubMed ID: 28623482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective diagnosis of acoustic neuromas: a philosophical, macroeconomic, and technological decision.
    Murphy MR; Selesnick SH
    Otolaryngol Head Neck Surg; 2002 Oct; 127(4):253-9. PubMed ID: 12402001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra high resolution nonenhanced fast spin echo magnetic resonance imaging: cost-effective screening for acoustic neuroma in patients with sudden sensorineural hearing loss.
    Daniels RL; Shelton C; Harnsberger HR
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):364-9. PubMed ID: 9781992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost effective screening protocol for vestibular schwannoma in the late 90s.
    Ravi KV; Wells SC
    J Laryngol Otol; 1996 Dec; 110(12):1129-32. PubMed ID: 9015424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real Incidence of Vestibular Schwannoma? Estimations From a National Registry.
    Kleijwegt M; Ho V; Visser O; Godefroy W; van der Mey A
    Otol Neurotol; 2016 Oct; 37(9):1411-7. PubMed ID: 27525713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic accuracy of non-imaging screening protocols for vestibular schwannoma in patients with asymmetrical hearing loss and/or unilateral audiovestibular dysfunction: a diagnostic review and meta-analysis.
    Hentschel M; Scholte M; Steens S; Kunst H; Rovers M
    Clin Otolaryngol; 2017 Aug; 42(4):815-823. PubMed ID: 27905190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental findings of a Vestibular Schwannoma on Brain MRI.
    Puls T
    B-ENT; 2015; 11(4):309-12. PubMed ID: 26891545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision and cost analysis in acoustic neuroma diagnosis.
    Bance ML; Hyde ML; Malizia K
    J Otolaryngol; 1994 Apr; 23(2):109-20. PubMed ID: 8028068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A standardised pathway for the surveillance of stable vestibular schwannoma.
    Shapey J; Barkas K; Connor S; Hitchings A; Cheetham H; Thomson S; U-King-Im JM; Beaney R; Jiang D; Barazi S; Obholzer R; Thomas N
    Ann R Coll Surg Engl; 2018 Mar; 100(3):216-220. PubMed ID: 29493353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Vestibular Schwannoma in Taiwan from 2001 to 2012: A Population-Based National Health Insurance Study.
    Koo M; Lai JT; Yang EY; Liu TC; Hwang JH
    Ann Otol Rhinol Laryngol; 2018 Oct; 127(10):694-697. PubMed ID: 30032646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution and Cost-Effectiveness of ABR and MRI in Acoustic Neuroma screening. Retrospective Study of 151 Cases].
    Portier F; Herman P; Lot G; Tran Ba Huy P
    Ann Otolaryngol Chir Cervicofac; 2002 Apr; 119(2):67-72. PubMed ID: 12015490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of vestibular schwannoma in Denmark, 1977-1995.
    Howitz MF; Johansen C; Tos M; Charabi S; Olsen JH
    Am J Otol; 2000 Sep; 21(5):690-4. PubMed ID: 10993460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence of vestibular schwannoma in Denmark].
    Stangerup SE; Caye-Thomasen P; Tos M; Thomsen JC
    Ugeskr Laeger; 2008 Oct; 170(42):3335-8. PubMed ID: 18940171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening patients with sensorineural hearing loss for vestibular schwannoma using a Bayesian classifier.
    Nouraei SA; Huys QJ; Chatrath P; Powles J; Harcourt JP
    Clin Otolaryngol; 2007 Aug; 32(4):248-54. PubMed ID: 17651265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vestibular schwannoma. Incidence of the disease and the consequences].
    Mirz F; Jørgensen BG; Pedersen CB
    Ugeskr Laeger; 1998 Nov; 160(45):6516-9. PubMed ID: 9816961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of vestibular schwannoma and incidental findings on the magnetic resonance imaging and computed tomography scans of patients from a direct referral audiology clinic.
    Wong BY; Capper R
    J Laryngol Otol; 2012 Jul; 126(7):658-62. PubMed ID: 22578280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.